Cholesterol drugs' benefits far outweigh side effects, review finds

Cholesterol drugs' benefits far outweigh side effects, review finds
But long-term use of statins may raise odds of diabetes among people with risk factors, experts say

(HealthDay)—The benefits of long-term use of cholesterol-lowering statin drugs greatly outweigh the risks, according to a review of research published over 20 years.

Some experts fear that statins may be overused, but these new findings could offer reassurance to the more than 200 million people worldwide who take the drugs, the review authors said. Common medications include Crestor, Lipitor and Zocor.

"For most at-risk patients, the cardiovascular benefits far exceed the risks," study author Dr. Chintan Desai, a clinical cardiology fellow at the Johns Hopkins Hospital, said in a Hopkins news release.

They analyzed data from studies conducted since 1994 that included more than 150,000 middle-aged and elderly men and women who took statins and were followed for about five years. The results showed that long-term statin use slightly increased the risk of some side effects but did not increase the risk for others.

For example, there was little evidence of muscle aches and pains and only a slight increase in the risk of . A serious condition featuring the rapid breakdown of was mainly associated with high doses of statins that are no longer recommended.

Long-term use of statins was associated with a modest increase in the risk of type 2 diabetes, but only among people who had other diabetes risk factors. People who took statins for a long time had low increased risk for dementia, blood clots, cataracts and fatigue.

The researchers also found that statin use offered some protection for people at risk for inflammation of the pancreas and for kidney disease caused by the dye used for some medical imaging procedures.

The study was published July 31 in the British Medical Journal.

More information: The U.S. National Library of Medicine has more about statins.

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Results of RIBS IV trial reported

5 hours ago

A new clinical trial comparing the use of everolimus-eluting stents (EES) and drug-eluting balloons (DEB) in treating in-stent restenosis (ISR) from drug-eluting stents found that EES provided superior late angiographic results ...

Results of DKCRUSH-VI trial reported

5 hours ago

A new study found that fractional flow reserve (FFR)-guided provisional side branch (SB) stenting of true coronary bifurcation lesions yields similar outcomes to the current standard of care. The DKCRUSH-VI clinical trial ...

Results of IVUS-CTO trial reported at TCT 2014

6 hours ago

A new study found that intravascular ultrasound (IVUS) -guided intervention in patients with chronic total occlusion (CTO) could improve outcomes compared to a conventional angiography-guided approach during percutaneous ...

Results of OCT STEMI trial reported at TCT 2014

6 hours ago

The first randomized trial to examine serial optical coherence tomography (OCT) in primary percutaneous coronary intervention (PCI) was reported at the 26th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific ...

INR variability predicts warfarin adverse effects

11 hours ago

(HealthDay)—Unstable anticoagulation predicts warfarin adverse effects regardless of time in therapeutic range, according to a study published online Sept. 2 in Circulation: Cardiovascular Quality and Ou ...

User comments